| 5280 |
Centers for Disease Control and Prevention |
Html |
en |
Science Clips - Monday, April 18, 2011 |
null |
| Apr | 0.771833 |
| urinary sodium excretion | 0.800284 |
| Four-year treatment outcomes | 0.792185 |
| Grunbaum JA | 0.796567 |
| Pediatr Infect Dis | 0.789708 |
| Front-of-pack nutrition label | 0.784291 |
| Marginal iodide deficiency | 0.785947 |
| ACE-27 comorbidity index | 0.792835 |
| diastolic blood pressure | 0.787605 |
| CDC Science Clips | 0.949152 |
| colorectal cancer screening | 0.798887 |
| Nutrition Examination Survey | 0.783664 |
| youth violence prevention | 0.790392 |
| Metal ions | 0.770594 |
| Pohl HR | 0.829844 |
| Chief Science Officer | 0.81008 |
| Met Ions Life | 0.969735 |
| group-level HIV/AIDS intervention | 0.785155 |
| American Heart Association | 0.805866 |
| Analytical performance issues | 0.786934 |
| PLoS Curr. | 0.765184 |
| Rift Valley fever | 0.791138 |
| direct-reading exposure assessment | 0.785094 |
| Stephen B. Thacker | 0.892602 |
| Behav Nutr Phys | 0.786601 |
|
| Natl Cancer Inst. | 0.797192 |
| Environmental Health Specialists | 0.809505 |
| healthier product development | 0.781127 |
| unintentional injury risk | 0.796022 |
| United States | 0.7833 |
| oral health component | 0.79553 |
| crossover clinical trial | 0.780401 |
| U.S. preventive services | 0.782802 |
| new funding cycle | 0.789423 |
| methicillin-sensitive S. aureus | 0.795625 |
| antiretroviral therapy program | 0.798022 |
| cardiovascular disease | 0.800282 |
| medical record review | 0.799919 |
| Human rhinovirus infections | 0.791755 |
| public health literature | 0.803279 |
| B. Thacker CDC | 0.938327 |
| systematic review | 0.789431 |
| quantitative pharmacokinetic modeling | 0.787641 |
| Fecal DNA testing | 0.800369 |
| community-associated Staphylococcus aureus | 0.798254 |
| original sources | 0.767912 |
| Ions Life Sci. | 0.971875 |
| parent mental distress | 0.784253 |
| Thacker CDC Library | 0.938305 |
|
CLICK HERE |
| 7315 |
Centers for Disease Control and Prevention |
Html |
en |
Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP) - United States, 2012-13 Influenza Season |
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. |
| ACIP Influenza Work | 0.239065 |
| 2012-13 influenza season | 0.223909 |
| currently available influenza | 0.232084 |
| seasonal vaccine | 0.29008 |
| Multiple influenza vaccines | 0.209171 |
| U.S.-licensed influenza vaccines | 0.20274 |
| available vaccine products | 0.248029 |
| Routine annual influenza | 0.205272 |
| live-attenuated influenza vaccine | 0.319245 |
| U.S. seasonal influenza | 0.232302 |
| children | 0.295709 |
| available influenza vaccines | 0.24819 |
| shows influenza vaccine | 0.284195 |
| seasonal influenza vaccine | 0.828822 |
| seasonal influenza vaccines | 0.304851 |
| live-attenuated vaccine virus | 0.216971 |
| influenza B vaccine | 0.280903 |
| ACIP annual vaccine | 0.229521 |
| influenza vaccine | 0.987659 |
|
| trivalent inactivated influenza | 0.331092 |
| seasonal vaccine antigens | 0.220423 |
| influenza season | 0.464918 |
| influenza vaccines | 0.480602 |
| quadrivalent influenza vaccines | 0.278239 |
| future influenza seasons | 0.207624 |
| Vaccine Dose Considerations | 0.200664 |
| U.S. influenza vaccines | 0.228385 |
| influenza vaccine components | 0.30879 |
| ACIP influenza statement | 0.200421 |
| influenza vaccination | 0.358732 |
| vaccine virus strain | 0.230576 |
| inactivated influenza vaccine | 0.453252 |
| annual influenza vaccination | 0.292249 |
| recommended annual influenza | 0.214901 |
| egg allergy | 0.276277 |
| influenza vaccine virus | 0.362274 |
| febrile seizures | 0.315858 |
|
CLICK HERE |
| 7482 |
Centers for Disease Control and Prevention |
Html |
en |
Healthy Housing Reference Manual - Chapter 5: Indoor Air Pollutants and Toxic Materials |
NCEH provides leadership to promote health and quality of life by preventing or controlling those diseases, birth defects, or disabilities resulting from interaction between people and the environment. Site has information/education resources on a broad range of topics, including asthma, birth defects, radiation, sanitation, lead in blood, and more. |
| airborne mold contaminants | 0.78907 |
| Mold Standards | 0.779125 |
| mold contamination problems | 0.804144 |
| different mold species | 0.800007 |
| mold contamination investigations | 0.792188 |
| house dust mites | 0.853096 |
| lung cancer | 0.822974 |
| Breathing asbestos fibers | 0.779558 |
| children | 0.82003 |
| mold spores | 0.817027 |
| mold growth | 0.870755 |
| mold remediation efforts | 0.786836 |
| soil air entry | 0.78118 |
| indoor environmental asthma | 0.798634 |
| intrinsic asthma | 0.787787 |
| asthma | 0.812385 |
| harmful indoor air | 0.792714 |
| indoor air pollutants | 0.869163 |
| exposure | 0.825226 |
| mold contamination | 0.812229 |
| indoor formaldehyde levels | 0.781815 |
| health effects | 0.82264 |
| asbestos | 0.837904 |
| air conditioning | 0.788606 |
|
| United States | 0.848387 |
| asbestos fibers | 0.825148 |
| mold abatement strategies | 0.78996 |
| asbestos material | 0.827123 |
| asbestos exposure | 0.790341 |
| airborne mold spores | 0.795378 |
| indoor air pollution | 0.865799 |
| low indoor air | 0.792278 |
| indoor mold distributions | 0.816397 |
| indoor air contaminants | 0.792292 |
| Mold Assessment Methods | 0.795949 |
| biologic pollutants | 0.804029 |
| outdoor air | 0.818795 |
| toxin-producing mold | 0.778434 |
| house dust mite | 0.803763 |
| outdoor air samples | 0.780804 |
| indoor air | 0.979081 |
| home | 0.816652 |
| mold problems | 0.803142 |
| mold exposure | 0.79473 |
| mold contamination extent | 0.789396 |
| Air pollutant levels | 0.797583 |
| single mold species | 0.799174 |
| levels | 0.803659 |
|
CLICK HERE |
| 7549 |
Centers for Disease Control and Prevention |
Html |
en |
Chikungunya Outbreak - Cambodia, February-March 2012 |
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. |
| chikungunya outbreak | 0.794807 |
| Public health agencies | 0.713331 |
| Cambodia | 0.779449 |
| National Malaria Center | 0.709499 |
| recent flavivirus infection | 0.710841 |
| Reunion Island outbreak | 0.712127 |
| local health centers | 0.719794 |
| Kampong Speu Province | 0.707414 |
| Kampong Speu | 0.74213 |
| CHIKV Asian strain | 0.72947 |
| Medical Research Unit | 0.953968 |
| U.S. Naval Medical | 0.773093 |
| Ae. albopictus | 0.734987 |
| IgM seroprevalence | 0.857291 |
| infected Aedes mosquitoes | 0.70941 |
| East/Central/South African strain | 0.776134 |
| CHIKV-positive cases | 0.70746 |
| positive PCR results | 0.711731 |
| CHIKV IgM-positive prevalence | 0.730337 |
| onset date | 0.738198 |
| health planning efforts | 0.762237 |
| age groups | 0.743967 |
| persons | 0.791686 |
| CHIKV outbreak | 0.759506 |
|
| Naval Medical Research | 0.950994 |
| CHIKV IgM | 0.832389 |
| Disease Control Department | 0.712736 |
| Institut Pasteur | 0.750346 |
| CHIKV | 0.911524 |
| current self-reported symptoms | 0.717023 |
| Phnom Penh | 0.846952 |
| anti-CHIKV IgM | 0.714581 |
| age group | 0.790799 |
| asymptomatic CHIKV infection | 0.745426 |
| chikungunya virus | 0.798895 |
| village residents | 0.759646 |
| Public Health Unit | 0.714618 |
| polymerase chain reaction | 0.838374 |
| cases | 0.738638 |
| CHIKV serologic study | 0.73061 |
| joint pains | 0.759003 |
| chikungunya reemergence | 0.788795 |
| chikungunya virus infection | 0.768117 |
| debilitating joint pains | 0.70529 |
| Communicable Disease Control | 0.786998 |
| clinical attack rate | 0.75226 |
| new variant chikungunya | 0.755087 |
| CHIKV IgM seroprevalence | 0.79312 |
|
CLICK HERE |
| 7605 |
Centers for Disease Control and Prevention |
Html |
en |
Multistate Meningitis Outbreak: Healthcare Facilities |
HAIs are associated with a variety of causes, including the use of medical devices, such as catheters and ventilators, complications following a surgical procedure, transmission between patients and healthcare workers, or the result of antibiotic overuse. |
| multistate outbreak | 0.715267 |
| treatment | 0.445329 |
| Center | 0.445492 |
| CDC | 0.46906 |
| vials | 0.467804 |
| patients | 0.539331 |
| tainted steroid injections | 0.976515 |
| complete list | 0.64211 |
| patient recovery | 0.65537 |
|
| BUD | 0.620338 |
| methylprednisolone acetate | 0.651696 |
| health care facilities | 0.840394 |
| New England Compounding | 0.895623 |
| infections | 0.544169 |
| clinicians | 0.67352 |
| relevant materials | 0.65122 |
| page | 0.443383 |
| web resources | 0.680139 |
|
CLICK HERE |
| 7771 |
Centers for Disease Control and Prevention |
Html |
en |
Hepatitis - Health Communication |
Hepatitis - Gateway to Health Communication - CDC |
| stool | 0.240325 |
| reason | 0.215351 |
| hepatitis B virus | 0.573065 |
| areas | 0.216078 |
| sewage-contaminated water | 0.281867 |
| common types | 0.291694 |
| direct contact | 0.348491 |
| hepatitis A. HAV | 0.657613 |
| chronic liver disease | 0.344311 |
| tip sheet | 0.447334 |
| casual contact | 0.355832 |
| liver transplants | 0.284569 |
| body fluids | 0.28326 |
| raw shellfish | 0.28654 |
| persons | 0.246573 |
| infected mother | 0.310224 |
| HCV | 0.260772 |
| poor sanitary conditions | 0.358321 |
| indication | 0.215296 |
| sex contact | 0.281377 |
| United States | 0.372135 |
| human blood | 0.275575 |
| certain behaviors | 0.277877 |
| HBV). | 0.329663 |
| inflammation | 0.2197 |
|
| infected people | 0.313471 |
| hepatitis C virus | 0.550658 |
| hepatitis viruses | 0.593016 |
| contaminated water | 0.288502 |
| long-term infection | 0.278431 |
| cirrhosis | 0.232659 |
| viral hepatitis | 0.75106 |
| factory | 0.21579 |
| Hepatitis C tip | 0.514155 |
| Hepatitis B tip | 0.528639 |
| long term infection | 0.342365 |
| hepatitis | 0.937368 |
| personal hygiene | 0.286563 |
| food | 0.231817 |
| hepatitis A virus | 0.597344 |
| infected person | 0.37176 |
| usual office | 0.286927 |
| mouth | 0.215888 |
| Hepatitis A tip | 0.549561 |
| HAV). | 0.345044 |
| school setting | 0.286575 |
| liver cancer | 0.284165 |
| information | 0.248437 |
| risk | 0.226906 |
|
CLICK HERE |
| 8331 |
Centers for Disease Control and Prevention |
Html |
en |
Youth Violence - Violence Prevention - Injury |
null |
| young person | 0.576849 |
| E. G. Krug | 0.764634 |
| World report | 0.631338 |
| Consistency | 0.515415 |
| peers | 0.51678 |
| protective factors | 0.572018 |
| physical force | 0.585063 |
| community services | 0.578355 |
| different forms | 0.657004 |
| (pp. | 0.636868 |
| offender | 0.51408 |
| property values | 0.576157 |
| results | 0.513691 |
| psychological harm | 0.598101 |
| jurisdictions | 0.514572 |
| World Health Organization | 0.737873 |
| disruption | 0.516372 |
| physical harm | 0.597994 |
| global public health | 0.633953 |
| schools | 0.515299 |
| J. A. Mercy | 0.744096 |
| justice costs | 0.576413 |
| L. L. Dahlberg | 0.766874 |
| Eds. | 0.525043 |
| consistent definition | 0.641123 |
|
| Examples | 0.514034 |
| intervention efforts | 0.572325 |
| Butchart | 0.518804 |
| death | 0.51364 |
| Geneva | 0.52762 |
| victimization | 0.517072 |
| turn | 0.513857 |
| young people | 0.642775 |
| youth violence | 0.98195 |
| magnitude | 0.51597 |
| victim | 0.513872 |
| power | 0.515105 |
| R. Lozano | 0.651744 |
| significant public health | 0.660188 |
| fights | 0.514892 |
| families | 0.515309 |
| Switzerland | 0.525255 |
| perpetration | 0.520083 |
| gang-related violence | 0.698095 |
| public health problem | 0.778579 |
| Farrington | 0.517236 |
| ages | 0.515159 |
| incidence | 0.514143 |
| A. B. Zwi | 0.743883 |
|
CLICK HERE |
| 10284 |
Centers for Disease Control and Prevention |
Html |
en |
Extreme Heat'CDC |
Information on extreme heat. Provided by the Centers for Disease Control and Prevention (CDC). |
| extreme heat | 0.96177 |
| website | 0.290702 |
| fact | 0.293042 |
| Heat-related deaths | 0.894531 |
| United States | 0.668598 |
|
| illnesses | 0.377883 |
| resources | 0.288987 |
| information | 0.28963 |
| helpful tips | 0.712284 |
|
CLICK HERE |
| 13466 |
Centers for Disease Control and Prevention |
Html |
en |
State School and Childcare Vaccination Laws -Publications by Topic - Public Health Law |
null |
| state statutes | 0.41772 |
| practice | 0.318564 |
| public health practitioners | 0.508373 |
| vaccination exemption laws | 0.672683 |
| children | 0.318966 |
| outbreak | 0.320164 |
| legal counsel | 0.406447 |
| private schools | 0.417359 |
| State laws | 0.451232 |
| recent updates | 0.396995 |
| relevant immunization laws | 0.491959 |
| school vaccination | 0.67542 |
| patients | 0.336744 |
| Vaccination Authority Laws | 0.663981 |
| Schmit C. Journal | 0.501449 |
| school vaccination requirements | 0.632413 |
| Vaccine Policies | 0.416479 |
| certain healthcare professionals | 0.517677 |
| article | 0.316871 |
| policy issues | 0.40325 |
| college/university students | 0.430283 |
| Healthcare Worker Vaccinations | 0.545847 |
| certain facilities | 0.421976 |
| School Vaccination Laws | 0.656857 |
| select state vaccine | 0.518842 |
|
| vaccination requirements | 0.656449 |
| document | 0.342317 |
| changes | 0.331739 |
| exemption application process | 0.520704 |
| Ethics | 0.316489 |
| PDF | 0.332694 |
| Barraza | 0.330719 |
| exemptions | 0.325928 |
| state health department | 0.500021 |
| scope | 0.318327 |
| workers | 0.318858 |
| 594KB | 0.316266 |
| Health Law Program | 0.810291 |
| Hoss | 0.326808 |
| rates | 0.316739 |
| resources | 0.317413 |
| state vaccination laws | 0.986382 |
| school vaccinations | 0.534845 |
| Medicine | 0.316502 |
| State law | 0.420439 |
| regulations | 0.316064 |
| Public Health Law | 0.799317 |
| daycare settings | 0.420228 |
| Pharmacist | 0.323923 |
|
CLICK HERE |
| 13477 |
Centers for Disease Control and Prevention |
Html |
en |
Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2015 | 16 Influenza Season |
Lisa A. Grohskopf, MD1; Leslie Z. Sokolow, MSc, MPH1,2; Sonja J. |
| ACIP Influenza Work | 0.574329 |
| licensed influenza vaccines | 0.573904 |
| influenza vaccine product | 0.599297 |
| quadrivalent influenza vaccine | 0.634145 |
| Influenza Vaccine Effectiveness | 0.588543 |
| inactivated influenza vaccines | 0.573275 |
| U.S. seasonal influenza | 0.598765 |
| influenza disease | 0.52758 |
| various influenza vaccine | 0.635509 |
| live attenuated influenza | 0.563985 |
| vaccine virus | 0.487265 |
| children | 0.523345 |
| IIV vaccine effectiveness | 0.498535 |
| trivalent influenza vaccines | 0.577797 |
| available influenza vaccines | 0.569935 |
| advisory committee | 0.484043 |
| stratis injector | 0.499218 |
| Lisa A. Grohskopf | 0.48171 |
| Quadrivalent influenza vaccines | 0.576377 |
| influenza illness | 0.526986 |
| influenza vaccine products | 0.65703 |
| seasonal influenza vaccines | 0.650334 |
| predominant influenza | 0.527004 |
|
| influenza vaccine | 0.912459 |
| influenza season | 0.594367 |
| influenza vaccines | 0.787697 |
| influenza activity | 0.541006 |
| well-matched influenza viruses | 0.543888 |
| Vaccine Dose Considerations | 0.499903 |
| recombinant influenza vaccine | 0.631828 |
| influenza vaccine components | 0.583611 |
| Vaccine Adverse Event | 0.483236 |
| H3N2 influenza viruses | 0.543477 |
| egg-based influenza vaccines | 0.558499 |
| influenza complications | 0.519485 |
| influenza virus circulation | 0.567306 |
| ACIP recommendations | 0.491809 |
| inactivated influenza vaccine | 0.645584 |
| Influenza Division | 0.513869 |
| influenza viruses | 0.582268 |
| annual influenza vaccination | 0.576821 |
| influenza B virus | 0.548428 |
| influenza virus | 0.570039 |
| culture-confirmed influenza | 0.547353 |
| LAIV4 vaccine effectiveness | 0.491004 |
|
CLICK HERE |